Reaction

Enterococcal Bacteraemia reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,042 reports · 71 co-occurring drugs

As of the last recalculation, Enterococcal Bacteraemia appears in 1,042 FAERS reports alongside 71 co-occurring drug terms. The strongest observed disproportionality signal is BUSULFAN (PRR 70.8).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Busulfan	53	70.8	71.1
Micafungin Sodium	28	67.8	68.0
Fludarabine Phosphate	113	64.3	64.4
Posaconazole Delayed-Release	29	54.2	54.4
Thiotepa	25	53.6	53.7
Atovaquone	20	50.6	50.7
Cefepime	35	50.4	50.6
Cefepime Hydrochloride	39	50.2	50.3
Ganciclovir Sodium	25	48.3	48.4
Ganciclovir	24	47.9	48.0
Posaconazole	36	45.8	45.9
Ampicillin	16	39.2	39.2
Ampicillin Sodium	16	39.2	39.2
Alemtuzumab	36	38.5	38.5
Cytarabine	104	38.3	38.4
Anti-Thymocyte Globulin (Rabbit)	15	37.7	37.7
Daptomycin	17	37.4	37.5
Melphalan	36	32.7	32.8
Voriconazole Injection	34	32.3	32.3
Melphalan Hydrochloride	39	32.2	32.3
Linezolid	45	31.5	31.6
Meropenem	48	31.3	31.3
Amphotericin B	19	30.8	30.9
Basiliximab	17	29.3	29.4
Methylprednisolone Acetate	11	27.7	27.8
Gentamicin	17	26.4	26.4
Mycophenolate Mofetil	152	26.0	26.0
Mycophenolate Mofetil Hydrochloride	152	26.0	26.0
Voriconazole	38	25.9	25.9
Cyclophosphamide Injection, Solution	187	25.5	25.5
Cyclophosphamide	187	25.5	25.5
Cyclophosphamide For Injection	187	25.5	25.5
Etoposide	85	25.1	25.1
Polatuzumab Vedotin	12	24.8	24.9
Vancomycin Hydrochloride	75	24.4	24.4
Vancomycin	66	24.3	24.3
Tacrolimus Ointment 0.1%	130	23.7	23.7
Tacrolimus Extended-Release Capsules	130	23.6	23.6
Gentamicin Sulfate	18	23.1	23.2
Axicabtagene Ciloleucel	11	22.5	22.5
Tacrolimus	151	22.4	22.4
Fluconazole	65	19.7	19.7
Bendamustine Hcl	15	19.6	19.6
Doxorubicin	78	18.8	18.8
Piperacillin Sodium And Tazobactam Sodium	18	18.6	18.6
Valganciclovir Hydrochloride Powder,	11	18.2	18.2
Valganciclovir	16	17.2	17.2
Valganciclovir Hydrochloride	16	17.2	17.2
Azacitidine For	14	15.6	15.6
Blinatumomab	8	15.4	15.4
Vincristine Sulfate	22	15.3	15.3
Filgrastim	28	15.3	15.3
Heparin Sodium	10	14.7	14.7
Dasatinib	25	13.7	13.7
Norepinephrine	7	13.2	13.2
Azacitidine	19	13.0	13.0
Acyclovir	69	12.9	12.9
Piperacillin And Tazobactam	8	12.6	12.6
Anakinra	10	12.1	12.2
Norepinephrine Bitartrate	8	11.2	11.2
Cladribine	5	10.4	10.4
Thalidomide	18	9.9	10.0
Mesna Injection	4	9.7	9.7
Ruxolitinib	33	9.5	9.5
Tofacitinib Citrate	6	9.2	9.2
Remdesivir	6	9.0	9.0
Cisplatin	34	9.0	9.0
Venetoclax	26	8.6	8.6
Gemcitabine	16	8.2	8.2
Alteplase	5	6.7	6.7
Paricalcitol	4	5.7	5.7

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.